The Global Debate on Obesity Management Medicines
About this episode
This episode explores the global debate on obesity management medicines, focusing on GLP-1 drugs and their implications for health equity and access.
Weight loss drugs are increasingly dominating headlines, but should they instead be understood as obesity management medicines? This episode of Connecting Citizens to Science explores the growing global debate surrounding GLP-1 medicines, obesity as a complex chronic disease, and the wider implications for health systems, equity and access across different global contexts. The discussion examines the benefits these medicines may offer beyond weight reduction, alongside concerns around affordability, regulation, stigma and widening inequalities between those who can access treatment safely and those who cannot. In this episode: Dr Fatima Cody Stanford - Associate Professor of Medicine and Pediatrics at Harvard Medical School and Massachusetts General Hospital. Dr Fatima is an obesity medicine physician-scientist whose work focuses on obesity as a chronic disease, cardiometabolic health and improving equitable access to evidence-based care. Alongside her clinical and research work, she contributes to national and international policy discussions through roles including the Lancet Commission on Obesity and the 2025 US Dietary Guidelines Advisory Committee, while also mentoring…
More episodes of Connecting Citizens to Science
- Understanding Gender as a System Part 1
- TB Realities in the UK and Globally
- Art and Activism for Gender Justice
- Disability and Gender Justice
- Allyship in Gender Justice
- Gender Backlash and the Erosion of Everyday Rights
Explore listener stats, chart rankings, contacts and more on the Connecting Citizens to Science podcast page.